Sam L Barker - Net Worth and Insider Trading
Sam L Barker Net Worth
The estimated net worth of Sam L Barker is at least $62,195 dollars as of 2024-11-13. Sam L Barker is the Director of Lexicon Pharmaceuticals Inc and owns about 52,187 shares of Lexicon Pharmaceuticals Inc (LXRX) stock worth over $62,103. Sam L Barker is also the Director of Cyclacel Pharmaceuticals Inc and owns about 225 shares of Cyclacel Pharmaceuticals Inc (CYCC) stock worth over $92. Details can be seen in Sam L Barker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sam L Barker has not made any transactions after 2021-11-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sam L Barker
Sam L Barker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sam L Barker owns 2 companies in total, including Cyclacel Pharmaceuticals Inc (CYCC) , and Lexicon Pharmaceuticals Inc (LXRX) .
Click here to see the complete history of Sam L Barker’s form 4 insider trades.
Insider Ownership Summary of Sam L Barker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals Inc | 2021-11-30 | director |
| LXRX | Lexicon Pharmaceuticals Inc | 2019-08-02 | director |
Sam L Barker Latest Holdings Summary
Sam L Barker currently owns a total of 2 stocks. Among these stocks, Sam L Barker owns 52,187 shares of Lexicon Pharmaceuticals Inc (LXRX) as of August 2, 2019, with a value of $62,103 and a weighting of 99.85%. Sam L Barker also owns 225 shares of Cyclacel Pharmaceuticals Inc (CYCC) as of November 30, 2021, with a value of $92 and a weighting of 0.15%.
Latest Holdings of Sam L Barker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2019-08-02 | 52,187 | 1.19 | 62,103 |
| CYCC | Cyclacel Pharmaceuticals Inc | 2021-11-30 | 225 | 0.41 | 92 |
Holding Weightings of Sam L Barker
Sam L Barker Form 4 Trading Tracker
According to the SEC Form 4 filings, Sam L Barker has made a total of 0 transactions in Lexicon Pharmaceuticals Inc (LXRX) over the past 5 years. The most-recent trade in Lexicon Pharmaceuticals Inc is the acquisition of 24,000 shares on August 2, 2019, which cost Sam L Barker around $28,320.
According to the SEC Form 4 filings, Sam L Barker has made a total of 2 transactions in Cyclacel Pharmaceuticals Inc (CYCC) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Cyclacel Pharmaceuticals Inc is the sale of 1 shares on November 30, 2021, which brought Sam L Barker around $43.
Insider Trading History of Sam L Barker
- 1
Sam L Barker Trading Performance
GuruFocus tracks the stock performance after each of Sam L Barker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sam L Barker is 44%. GuruFocus also compares Sam L Barker's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sam L Barker within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sam L Barker's insider trading performs compared to the benchmark.
Performance of Sam L Barker
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.62 | | | | | |
| Relative Return to S&P 500(%) | 0.9 | | | | | |
Sam L Barker Ownership Network
Ownership Network List of Sam L Barker
Ownership Network Relation of Sam L Barker
Sam L Barker Owned Company Details
What does Cyclacel Pharmaceuticals Inc do?
Who are the key executives at Cyclacel Pharmaceuticals Inc?
Sam L Barker is the director of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & President & C.E.O. Spiro Rombotis , director & E.V.P. & Finance & C.O.O. Paul Mcbarron , and Chief Medical Officer Mark Kirschbaum .
Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary
Over the past 18 months, Sam L Barker made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .
In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.
Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclacel Pharmaceuticals Inc Insider Transactions
Sam L Barker Mailing Address
Above is the net worth, insider trading, and ownership report for Sam L Barker. You might contact Sam L Barker via mailing address: 51 Aunt Molly Road, Hopewell Nj 08525.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
